Vladimir Skljarevski

Vladimir Skljarevski is a US and EU trained neurosurgeon with 20+ years of experience in neuroscience drug development (phase 1-4). He has a proven track record of designing and executing global clinical trials, successful INDs, and NDAs, with FDA and other major regulatory agencies. He is currently serving as interim Chief Medical Officer at Tetra Therapeutics. He previously was the VP of Clinical Development at Axial Therapeutics, Executive Medical Director at Cortexyme, and he spent 20 years at Eli Lilly and Company.